Neurology

Article	Citations
Intravenous Immune Globulins vs Plasma Exchange Usage in Patients with Neuromuscular and Neuro-immunological Conditions (P4-13.007)	301
Increased Healthcare Cost and Mental Health Burden among Patients with Essential Tremor: A Retrospective Observational Study in A Large US Commercially Insured and Medicare Advantage Population (P15-1	271
Postpartum Risk of Cerebral Venous Thrombosis (P10-10.006)	256
Towards Machine Learning-Based Cognitive Examination (S2.010)	207
Reduced Time to Treatment After Implementation of a Standardized Guideline for the Diagnostic Evaluation and Acute Management of Suspected Autoimmune Encephalitis in Hospitalized Adult Patients (P9-8.	173
Teaching NeuroImage: Foramen Magnum Dural Arteriovenous Fistula Presenting With Thoracolumbar Myelopathy	171
Spinal Cord Infarction Associated with Patent Formale Ovale and Venous Thromboembolism: A Case Report (P8-13.005)	165
Standardized Inpatient Telestroke to Improve Access to Stroke Specialists (P12-14.015)	158
Improving Median Overall Survival (OS) of Glioblastoma (GBM) Patients by Optimizing Standard of Care (SOC) Through Multidisciplinary Team Work and Combination Therapies Including Tumor Treating Fields	157
Frailty increases the risk of Alzheimer’s disease in non-demented individuals: a longitudinal cohort study (P6-3.008)	140
Role of the UNC13 Family in Human Diseases: A Literature Review (P9-2.003)	139
Predicting Cognitive Decline Using Baseline Data in Cognitively Unimpaired Older Adults: Results from the A4 Trial (P2-3.018)	137
Rational Design of a Vaccine for Synucleinopathies Using Computationally-Derived Conformational B Cell Epitopes To Selectively Target Pathogenic Alpha-Synuclein Species (P8-3.007)	131
Traumatic Brain Injury and Depressive Symptoms in Community Dwelling Older Adults (P3-4.007)	128
The Boston Criteria v2.0 for Cerebral Amyloid Angiopathy	127
Lifestyle Contributors to Frequent Headaches in Youth	127
Exploring Clinical Outcomes of ABCDEF Bundle Implementation in Neurocritical Patients: Insights from Two Years of ICU Humanization (P9-7.006)	122
Multicenter Post-approval Study of the RNS System in Focal Epilepsy (S20.009)	122
Analysis of the Efficacy of Efgartigimod in a Refractory OMG Patient (P1-11.019)	118
Frequency and Severity of Neurological Symptoms Following Gluten Exposure in Individuals with Celiac Disease (P1-2.010)	111
Impact of Psychiatric Conditions on the Real-world Effectiveness of Eptinezumab Treatment in Patients with Chronic Migraine (P4-12.005)	110
Association Between COVID-19 Vaccination and Rhabdomyolysis in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study (S18.006)	106
A Clinical Decision Rule Predicting Outcomes of Emergency Department Patients with Altered Mental Status (P5-12.003)	102
Vision-Specific Quality of Life in Patients with Post-Acute Sequelae of COVID-19 (PASC) (P18-12.005)	99
Association Between COVID-19 Vaccination and Cerebrovascular Accidents in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study (S18.002)	99

A Clinical Bulbar Assessment Scale for ALS/MND: Preliminary Validation (S11.007)	98
Cenobamate Plasma Concentrations in Patients Reaching ≥50% or 100% Responder Rates for ≥12 Months: A Post-hoc Analysis (S13.004)	92
Peripheral Neuropathy	90
Teaching Video NeuroImage: Pattern-Induced Seizures Without Photosensitivity in Glutaric Aciduria	87
Author Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM	82
Development and Validation of a Nomogram Prediction Model for New Stroke in Community Population (P10-13.004)	82
Author Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM	82
Variation in Resting Metabolic Rate Affects Identification of Metabolic Change in Geographically Distinct Cohorts of Patients With ALS	82
Perspectives From Members of an Online Community on Their Communications With Health Care Professionals About Migraine Treatment: A Social Listening Analysis (P17-2.003)	82
Bilateral temporal lobe epilepsy: How many seizures are required in chronic ambulatory electrocorticography to estimate the laterality ratio? (S7.010)	81
Amyloid beta deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort (P1-1.Virtual)	81
Early Neurological Improvement Can Reduce Intensive Care Unit Length of Stay in Aneurysmal Subarachnoid Hemorrhage (P12-10.008)	80
Pathogenic Th17 Cells in Autoimmune Myasthenia Gravis Exhibit a Pro-inflammatory Transcriptomic Signature that Promotes Disease Pathogenesis (S41.008)	78
Motor Outcomes to Validate Evaluations in Facioscapulohumeral muscular dystrophy (MOVE FSHD): Protocol for an observational study. (S29.007)	78
Quantitative Cerebrovascular Reactivity Atlas In Children (P14-5.003)	77
Completing the NIHSS Score Prior to CT Scan to Reduce Time to Acute Intervention for Stroke: A Quality Improvement Project (P17-10.008)	77
Adaptive B-cell and T-cell responses to SARS-CoV-2 vaccination in patients with Multiple Sclerosis on disease modifying immunotherapy (S5.006)	77
Long-term Treatment with Galcanezumab in 29 Patients with Chronic Migraine: Results from the 3-year Continued Access Program of the REGAIN Study (P1-1.Virtual)	76
Resting-state Regional Cerebral Blood Flow Alterations in Macrovasculature and Microvasculature in Parkinson’s Disease: A Systematic Review and Meta-analysis (P3-5.013)	74
Automated Data Extraction Using Large Language Models in Vascular and Interventional Neurology Research: Towards an AI Fully Assistant Automated Research (P9-14.007)	73
Rethinking Thunderclap Headaches: A Critical Look at Cerebral Venous Sinus Thrombosis (P3-13.020)	73
Exploring Racial Disparities in Advanced Care Planning Documentation for Stroke Patients (P10-13.020)	73
Demographic and Regional Trends of Meningitis-related Mortality in the United States from 1999 to 2020: a CDC WONDER Analysis (P3-10.004)	70
Brain Perfusion Imaging and Cardiac Thrombus Detection	70
IgG4-Related Hypertrophic Pachymeningitis Mimicking Neuromyelitis Optica: a Case Report (P10-8.004)	70
Effectiveness of Ataluren in Patients with nmDMD: Confirmatory Evidence from the STRIDE Registry (P7-6.008)	70
Capturing Patient and Caregiver Perspectives on Parkinson’s Disease in Zambia: A Methodology (P6-11.014)	69
Modifiable Vascular Risk Factors and Subsequent Brain Metrics in Hispanic/Latino Populations	69
Elevated Pre-hospital Blood Pressure is Associated with Reduced Infarct Volume in Large Vessel Occlusion Ischemic Strokes (P12-13.016)	68
Patient Education and Unmet Needs: Pregnancy and Postpartum Counseling in MS (P6-1.014)	68
Clinical and Genetic Profiles of Congenital Myasthenic Syndromes: A Single Tertiary Care Center Experience from Saudi Arabia (P12-11.029)	68
Evaluating Brain Health in Women	68
Residual Symptoms and Long-term Outcomes after All-Cause Autoimmune Encephalitis (P5-1.002)	67
Distinguishing Quantitative EEG Correlates of Psychogenic Non-Epileptic Seizures versus Epilepsy (P1-1.Virtual)	67
Clinical evidence that treatment with pepinemab, a novel regulator of neuroinflammation, provides cognitive benefit to patients with Huntington’s and potentially other neurodegenerative diseases (P3-1	67
Teaching Video NeuroImage: Reflex Epilepsy—Seizures Triggered by a Geometric Pattern	67
Diagnosis of Stroke and Prognosis of Interventions Using Imaging and Machine Learning (P1-1.Virtual)	67
Descriptive Analysis of Acute Ischemic Stroke in COVID-19 Patients Through The Course of COVID-19 Pandemic (P18-10.009)	67
Long-term survival and cognitive function follow up of primary CNS lymphoma treated with R-MVP followed by high dose chemotherapy with autologous stem cell transplant consolidation (S27.008)	66
Real-World Experience of Perampanel Monotherapy in Epilepsy Patients with Focal-Onset and Generalized-Onset Seizures (P15-8.002)	65
Sustainability of Seizure Control With Adjunctive Cenobamate in the Phase 3 C021 Study (P12-8.001)	65
Study Design of AOC 1001-CS1, a Phase 1/2 Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AOC 1001 Administered Intravenously to Adult Patients with Myoton	65
Ponesimod Shows Improved Effect on Brain Volume Compared with Other DMTs, A Model Based Meta-Analysis (P1-1.Virtual)	64
Open-ended, value-based decision making requires semantic memory: a computational, imaging, and clinical study (P1-6.005)	64
BRAT1 Associated Leukodystrophy exacerbated by Lymphoma directed Chemotherapy (P13-9.005)	64
The Association of Posterior Reversible Encephalopathy Syndrome with COVID-19: A Systematic Review (P1-1.Virtual)	64
Novel Ischemic Stroke Treatment Protocol for Salvageable Penumbra in Acute Small Vessel Disease (S6.010)	63
Serving Los Angeles County Patients with Teleneurology, A Clinical Tool Here to Stay (P18-8.007)	63
Cardiac MRI in Duchenne and Becker Muscular Dystrophy (P14-13.001)	63
Temporal Mapping of Trigeminal Neuralgia Lesions to Symptom Onset in Multiple Sclerosis: When Do the Lesions Occur and What Do They Tell Us? (P16-4.001)	62

Prevalence of Comorbidities in a National Sample of Lewy Body Dementia Caregivers (P15-3.005)	62
Improved Access to Rapid Electroencephalography at a Community Hospital Reduces Inter-Hospital Transfers for Suspected Non-Convulsive Seizures (P6-8.003)	61
Delayed Toxic Encephalopathy Masquerading as Creutzfeldt-Jakob disease (P2-9.007)	61
Artificial intelligence identifies spectral biomarkers for use in adaptive deep brain stimulation in Parkinson’s disease (S16.004)	61
Wobbling Through the Spectrum: Anti-GQ1b Antibody Syndrome Presenting with Generalized Myoclonus and Ataxia (P4-8.018)	61
Comparison of Pharmacokinetic Profiles and Safety Outcomes with Peginterferon Beta-1a Administration in Black/African American and White Participants (P4-4.009)	61
A Novel IONM Protocol for Distal Femoral Extension Osteotomies (P6-6.010)	61
VGL101: An Immunotherapy that Enhances Microglial Survival for Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) (P9-9.013)	60
Outcomes of a Three Week Interdisciplinary Intensive Outpatient Treatment Program for Mild-Moderate Traumatic Brain Injury in Veterans and First Responders (P7-4.006)	59
Case Report of a Unique Structural Cause for Rapidly Progressive Orthostatic Syncope (P7-2.001)	59
Overdiagnosis of Autism Spectrum Disorder: Diagnostic and Management Challenges in a Pediatric Outpatient Clinic (P6-6.003)	59
Having Second Thoughts About Parkinson Diagnosis	58
The Role of Endothelin-1 in Hypoxia-Induced Inflammation and Oxidative Stress in Microglial Cells (P4-13.001)	57
Distinguishing Features of MOG Positive and MOG Negative Pediatric Patients with ADEM (S2.008)	57
Quantitation of Hypocretin Neuropeptides (Orexin-A and -B) in Human Cerebrospinal Fluid via HPLC with MS/MS Detection (P1-4.002)	57
NETSseq Identifies Novel Therapeutic Targets for Neurodegenerative Diseases (P3-3.008)	57
Hereditary Transthyretin Amyloidosis at Geisinger Medical Center: A Four-year Multidisciplinary Clinic Experience (P6-11.033)	57
Consent Deviations in an Acute Ischemic Stroke Clinical Trial (P5-13.017)	57
Colchicine Use and Risk of Stroke Recurrence in Acute Non-Cardiogenic Ischemic Stroke Patients: A Systematic Review and Meta-analysis (P4-14.006)	56
Localizing Lesions in the Peripheral Nervous System using Generative Artificial Intelligence (P1-2.009)	55
Effect Sizes of Once-daily Valbenazine for Chorea Associated with Huntington’s Disease: A Post-hoc Analysis of KINECT®-HD Data (P10-5.012)	55
Spontaneous Closure Of A Dural Arteriovenous Fistula: A Case Report (P5-14.011)	55
Pediatric SMART Syndrome in a 10-year-old boy: A Case-Report (P5-6.005)	55
Radiological Signs in Spinal Cord Infarct (SCI) and Association with Anatomic Location. (P9-13.005)	54
The Midbrain Paradox: Bilateral Vertical Gaze Palsy from a Single Sided Lesion (P2-11.007)	54
Severity of Hearing Loss as a Predictor of Dementia Risk: Insights from the ARIC Study (P9-3.013)	54
Inter-Institutional Collaborative Opportunity For Medical Students in the Neurosciences: Annual Student Interest Group in Neurology (SIGN) Forum (P5-5.021)	53
Multimodal Regression Based Assessment of Longitudinal Evolution Trends in Inflammatory Myositis (IIM) (P3-11.018)	53
Teaching Neuro Images : CNS actinomycosis in an immunocompetent patient	53
Comment: Introducing Neuromodulation in 2035	53
Comparative Efficacy of Adjuvant Rifampicin, Levofloxacin, and Their Combination in Tuberculous Meningitis With and Without HIV Co-infection: A Systematic Review and Meta-Analysis	52
My First Patient With Alzheimer's	52
Reader Response: Teaching NeuroImage: Cryptococcal Meningoencephalitis With Cryptococcoma and Gelatinous Pseudocysts	52
Incidence of Relapses After Meningococcal Vaccination in Clinical Trials of Eculizumab and Ravulizumab in Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)	52
Teaching NeuroImage: Seizures as the Initial Symptom of Relapsing Polychondritis	52
Measles, Rubella, and Varicella-Zoster Viral Antibodies and Clinical Prognosis After 20 Years in Persons with Multiple Sclerosis	52
Reader Response: Use of Social Media in Health Care—Opportunities, Challenges, and Ethical Considerations: A Position Statement of the American Academy of Neurology	52
Neuropsychologic Impact of MOGAD: A Patient Reported Outcomes Study	51
Characterizing Double-Negative Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Meta-Analysis	51
Characterization of Clinical Course, Diagnosis, Treatment, and Outcomes of Intravascular Lymphoma with Neurologic Involvement	51
Author Response: D313Y Variant in Fabry Disease: A Systematic Review and Meta-analysis	50
Coexistance of Probable Neurosarcoidosis and Generalized Myasthenia Gravis: Case Report	50
Glial Fibrillary Acidic Protein (GFAP) Antibody-Associated Astrocytopathy in Systemic Sarcoidosis	50
Association of Blood Pressure Variability With Death and Discharge Destination Among Critically Ill Patients With and Without Stroke	50
A Broader Perspective on Motor Rehabilitation Guidelines for Cerebral Palsy	50
NMDA Receptor Encephalitis With Severe Orofacial Dyskinesias Treated With Tramadol and Clonazepam	50
Assessing the Impact of Immune Checkpoint Inhibitor Therapy on Disease Activity in Multiple Sclerosis Patients	50
Opinion & Special Articles: The Core Identity of the Neurologist	49
Child Neurology: Creatine Biosynthesis Disorder in an Adolescent With Capgras Syndrome and Reduplicative Paramnesia	49
Leucine Zipper 4 Autoantibody–Associated Myeloneuropathy With Multiple Cranial Neuropathies and Longitudinally Extensive Tractopathy	49
Reframing Conceptions of Surgical Candidacy	49
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis	49
Association of APOE ε4 Status With Long-term Declines in Odor Sensitivity, Odor Identification, and Cognition in Older US Adults	49
Risk of Seizure Associated With Concomitant Use of Tramadol and Antidepressants in Older Nursing Home Residents	49
What Is the Role of Norepinephrine in Cerebellar Modulation and Stress-Induced Episodic Ataxia?	49
Contributions of Purine Synthesis and Recycling During Brain Development: Relevance to Lesch Nyhan Disease (S39.009)	48
Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial	48
Hard Times for Anticoagulation in Cancer-Associated Stroke	48
Classifying Papilledema Using Machine Learning – Modernizing Frisén Grading (S12.001)	48
Long-Term Fatigue Following Transient Ischemic Attack	48
Pearls & Oy-sters: Tumefactive Demyelinating Lesions With MOG Antibodies Preceding Late Infantile Metachromatic Leukodystrophy	48
The Importance of Offering Genetic Counseling and Testing to All Persons Diagnosed With Frontotemporal Degeneration Spectrum Disorders	47
Editors' Note: Sex-Dependent Effects of Cardiometabolic Health and APOE4 on Brain Age: A Longitudinal Cohort Study	47
Target Trial Emulation	47
Seizure Forecasting by High-Frequency Activity (80–170 Hz) in Long-term Continuous Intracranial EEG Recordings	47
Influence of Hospital Type on Outcomes of Patients With Acute Spontaneous Intracerebral Hemorrhage	47
New Requirements in the Reporting of Randomized Controlled Trials Published in Neurology to Foster Greater Transparency	47
Clinical Reasoning: A 56-Year-Old Woman With Right-Sided Weakness and Recurrent MRI Lesions	47
Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent	47
Jugular Variant Bow-Hunter’s Syndrome from Sternocleidomastoid Entrapment of the Internal Jugular Vein (P11-10.001)	46
Editors' Note: Association Between Induced Burst Suppression and Clinical Outcomes in Patients With Refractory Status Epilepticus: A 9-Year Cohort Study	46
Lysine Reduction and Cognitive Outcomes in Pyridoxine-Dependent Epilepsy	46
Author Response: Effect of Levetiracetam Use Duration on Overall Survival of Isocitrate Dehydrogenase Wild-Type Glioblastoma in Adults: An Observational Study	46
Teaching NeuroImage: Claustrum Sign in Febrile Infection–Related Epilepsy Syndrome	46
Racial and Socioeconomic Disparities in Ischemic Stroke Outcomes among Non-lytic/Thrombectomy Patients (P7-5.008)	46
Acoustically Altered Speech Perception in Frontotemporal Dementia Syndromes	46
Performance Assessment of the New EUROLINE Neurologic Syndrome 15 Ag (IgG) for the Determination of Autoantibodies Associated with Neurological Disorders	46
Teaching NeuroImage: Cryptococcal Meningoencephalitis With Cryptococcoma and Gelatinous Pseudocysts	46
Nitrous Oxide-Induced Vitamin B12 Deficiency and Myelopathy: A Report of Two Cases (P11-2.006)	45
A Rare Case of Giant Cell Arteritis Presenting With Transient Polycranial Neuropathies (P6-12.004)	45

A Case of Contrast-Induced Encephalopathy in The Setting of Acute Stroke Thrombolysis (P1-1.Virtual)	45
Variants in PNPLA8 are Associated with Developmental Epileptic Encephalopathy and Cerebellar Atrophy. (P6-5.002)	45
Group D Salmonella Meningitis in the Neonate (P5-6.010)	45
Autoimmune Cerebellar Ataxia Associated with TNF-Alpha Blocking Therapy in a Patient with Rheumatoid Arthritis: A Case Report and Literature Review (P8-8.003)	45
Accurate Test of Limb Isometric Strength (ATLIS) as an Outcome Measure in ALS and as a Marker of Upper Motor Neuron Involvement in Primary Lateral Sclerosis (S11.010)	45
Risk and Predictors of Relapse after Smoking Cessation in Patients with Ischemic Stroke and Transient Ischemic Attack (P1-1.Virtual)	44
Functional Parcellation of the Cingulate Gyrus in Epilepsy Surgical Planning: Electrical stimulation, Electrocorticography, and fMRI study (P4-8.005)	44
Lest We Forget: Ammonia in Encephalopathic Cancer Patients (P1-1.Virtual)	44
Proteomic profiling of sporadic late-onset nemaline myopathy (P15-13.001)	44
An IDH Wildtype, EGFR Amplified and TERT Promoter Mutated Astrocytoma that is Clinically and Molecularly Incompatible with the Diagnosis of Glioblastoma, IDH Wildtype. (P13-9.001)	44
Anti-IgLON-5 Associated Neurological Disease Presenting with Bilateral Optic Neuritis, Orthostatic Intolerance, Sleep-Related Movements in Setting of Testicular Mass: Expanding Clinical Phenotypes in	44
Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects the Blood-Brain Barrier after Stroke (S33.001)	44
Approach to patients with autoimmune encephalitis with no identifiable antibodies (P2-1.001)	44
Neuroradiological profile of Rhinoorbitocerebral mucormycosis in COVID-19 pandemic. (S18.007)	44
Assessing Social Cognition Across Dementia Subtypes (P6-6.004)	43
Acute Anterograde Amnesia with Bilateral Hippocampal and Globus Pallidus Lesions (P4-12.007)	42
Glymphatic Impairment in Multiple Sclerosis: A New Pathological Mechanism Associated with Disease Burden (S5.010)	42
Experiences with a virtual nationwide seminar series for neuroimmunology trainees (P14-6.001)	42
Psychometric Evaluation of the Idiopathic Hypersomnia Severity Scale (P1-7.001)	42
In-Hospital Glucose Measurements are Associated with Mortality after Thrombectomy for Acute Ischemic Stroke (P4-10.005)	42
Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant (P11-11.008)	42
Glucocerebrosidase Deficiency Mediates Propagation of Protein Aggregation in Neurodegeneration via Modification of Extracellular Vesicles (S36.006)	41
Data-Driven Genome-Wide Association Study of Pain Trajectories in Persons with Parkinson’s Disease (P7-11.012)	41
Improving Residents’ Knowledge and Interest in Outpatient Neurology through an Interactive, Discussion-Based, Patient-Centered Didactic Series (P2-2.006)	41
Iron accumulation correlates with disease severity in patients with Multiple System Atrophy (P15-11.002)	41
The Bulbar Imposter: A Case Presentation of Foix-Chavany-Marie Syndrome (P10-10.001)	41
Health Care Delivery and Financial Considerations in Amyotrophic Lateral Sclerosis Clinics	41
The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006)	41
Determinants of Disparate Disability Accumulation in Black, Hispanic, and White Patients With Multiple Sclerosis (P1-1.Virtual)	41
Neurocognitive Manifestations of Individuals with NF1 Microdeletions (P14-9.007)	41
Analysis of the Epidemiologic Profile, Prevalence, and Incidence of Migraine out of 15,490 Spontaneous Intracranial Hypotension Patients from a Multicenter Record Database (TriNetX) (P2-12.008)	41
Impact of Multiple Sclerosis Disease-Modifying Therapies on Effectiveness of SARS-Cov-2 Vaccines: A Longitudinal Total Population Study of National Health Service (NHS) England (S5.008)	41
Preclinical Development of a T Cell Receptor-engineered Regulatory T Cell Therapy for Progressive MS (S17.004)	40
Assessing Undergraduate Neurology Pipeline Programs: A Systematic Review (P11-2.001)	40
Survival and Clinical Characteristics of Patients with Glioblastoma with Primitive Neuronal Component (P13-13.004)	40
MOG Antibody-Associated Bilateral Optic Neuritis Associated with Johnson and Johnson COVID-19 Vaccination (P12-3.009)	40
Elevated Level of DNA Damage and Impaired Repair of DNA Oxidative Damage in Multiple Sclerosis Patients (P7-6.010)	40
MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes (P13-5.020)	40
Serum Glucose Fluctuations Is an Independent Predictor of Adverse Outcomes in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment (P7-5.014)	40
African-Americans With Multiple Sclerosis Have a Higher Proportion of B-Cell Lineage Cells in Their Cerebrospinal Fluid (CSF) Than White Patients (P9-3.010)	40
Machine-learning Assisted Swallowing Assessment: A Deep Learning-based Quality Improvement Tool to Screen for Post-stroke Dysphagia (S6.004)	40
Identification of a Novel NOTCH3 Mutation in a Case of CADASIL Initially Diagnosed as Demyelinating Disease (P3-3.010)	39
Gadolinium Enhancement Patterns in Leptomeningeal Disease (P2-2.001)	39
Evaluating Quality of Website-Derived Concussion Information (P8-1.005)	39
Patterns of Benzodiazepine Initiation Among Older Acute Ischemic Stroke Survivors (P1-10.006)	38
Patient Sera from the First Week Postpartum after Preeclampsia Increase Human Blood Brain Barrier Permeability (S25.003)	38
Development of eIF2B Activator ABBV-CLS-7262 as a Novel Treatment for Vanishing White Matter Disease (P2-8.001)	38
Tenecteplase Is a Better Alternative to Alteplase for Patients With Large Vessel Occlusion Stroke Receiving Bridging Therapy	38
Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment (P6-12.011)	38
A Gender Affirming Experience; The RNS System Tracking Seizure Frequency During Gender Changing Hormonal Therapy (P5-9.006)	38
Metronidazole Induced Encephalopathy Responsive to High Dose Thiamine (P4-12.006)	38
Pathologically- confirmed Osmotic Demyelination in the Case of Clinically and Radiographically Progressive Encephalopathy due to Liver Disease and Malnutrition. (P4-4.007)	38
Levamisole-associated Toxic Multifocal Inflammatory Leukoencephalopathy: A Case Report (P7-3.006)	38
COVID-19 Disrupts Sleep Architecture by Reducing N3 Stage Sleep (S25.010)	38
Tuberculous Meningitis: Is the Fixed Dose Anti-TB treatment strategy effective? Case report from Sri Lanka (P3-10.002)	38
Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis (P14-3.017)	37
Computational Models of Age-associated Cognitive Slowing and Memory Loss (P6-9.010)	37
Reconsidering the Ethics of Provocation Techniques for Psychogenic Non-epileptic Seizures and Proposed Ethical Guidelines for Use (P2-10.005)	37
Recognizing Neuropathic Pain as a Symptom of Charcot-Marie-Tooth Disease that impacts Quality of Life (P14-8.005)	37
4 mA tDCS improves walking ability in PSP: A case study (P9-11.012)	37
Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study (P13-5.003)	37
Association of Subthalamic Beta Frequency Sub-bands to Symptom Severity in Patients with Parkinson’s Disease: A Systematic Review (P5-11.014)	37
‘Code Brain’- Mannequin Based Simulation Exercise to Enhance Identification, Evaluation, and Management of Cerebral Herniation for Neurology Residents. (P5-5.027)	37
Designing Transgene Vectors for ALS Therapeutics (P11-4.010)	37
A Ten-year Delayed Diagnosis of Hereditary Spastic Paraplegia Type-10: Key Clinical, Electrodiagnostic, and Genetic Findings (P11-11.004)	36
A pioneer in the History of Women in Neurology - Historical Review of the Life and Contributions of Augusta Déjerine-Klumpke (P4-11.009)	36
Serum Neuroinflammatory Biomarkers and Long-term Cognitive Dysfunction (P11-13.002)	36
Multimodal Approach to NMOSD Relapse Treatment: Experience with Two Cases (P10-8.011)	36
Pearls & Oy-sters: Severe Myotonic Crisis Resembling Malignant Hyperthermia	36
Role of 18F-Florzolotau PET in Diagnostic and Therapeutic Decision-Making for Cognitive Impairment (N4.001)	36
Role of Pre-operative Mild Cognitive Impairment in Patients Undergoing Deep Brain Stimulation for Parkinson’s Disease: Systematic Review (P2-3.011)	36
Endovascular Therapy for NIHSS ≤5	36
What’s that Mass? A Sphenoid Lesion Causing Cavernous Sinus Syndrome (P3-14.009)	36
Neuroimaging Evidence of Cortical-subcortical Network Involvement in Patients with Cortical Lateralized Periodic Discharges (P5-1.004)	36
Personalized Alzheimer’s Risk Reduction Software Improves Calculated Alzheimer’s Risk: A Digital, Decentralized, Randomized Controlled Trial (P1-3.004)	35
The iNPH Radscale May Better Predict Whether Ventriculoperitonal Shunting was Offered, Compared to Drain Trial Gait Variables (P1-5.022)	35
Characteristics of Adult Essential Tremor Patients Seeking Participation in a Decentralized US Clinical Trial: Pre-screener Findings from the Essential3 Program Evaluating Efficacy and Safety of Ulixa	35
Opicapone as First-line Strategy for the Treatment of Wearing-off in Patients with Parkinson’s Disease (P7-5.026)	35
7T MRI Leptomeningeal Enhancement and Brain Atrophy Are Associated with Alterations in Arginine-polyamine Metabolism in Multiple Sclerosis (P11-6.007)	35
Drug-Resistant GAD65-Associated Epilepsy: Pre-Surgical Evaluation and Comparison to Temporal Lobe Epilepsy of Other Etiology (P2-9.005)	35
Perceived Stress and its Association with Sleep Quality in Patients with Neuropathic Pain and Distal Symmetric Polyneuropathy (P3-11.020)	35
Pregnancy-related Anticipatory Guidance for People with Epilepsy in Pediatric and Adult Neurology (P1-9.015)	35
The Safety and Efficacy of Chronic Weekly Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis (MG0004) (P4-14.017)	35
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) and Anti-N-Methyl-D-Aspartate Receptor Encephalitis (NMDARE) Overlapping Syndrome Presenting as Tics and Cognitive Symptoms (P10	35
The Path to Finding a Unifying Diagnosis – A Case Report of Mitchell Syndrome in a Pediatric Patient (P2-8.005)	35
Racial Disparities in Mental Health Among Stroke Survivors in the REDUCE Study (P1-13.014)	35
Focal Cerebral CNS Vasculitis due to SARS-CoV-2 Infection (P4-10.007)	35
Prospective Long-term Seizure Outcomes in Medically-resistant Focal Epilepsy Subjects with Neuromodulation Devices (P3-1.009)	34
Physiological β-Amyloid Clearance by the Liver and Its Therapeutic Potential for Alzheimer’s Disease (P12-3.010)	34
Blood Pressure Variability as a Marker of Sympathetic Hyperreactivity in Postpartum Patients with Preeclampsia, with and without Chronic Hypertension (P2-7.003)	34
Teaching NeuroImage: Wallerian Degeneration of the Corticospinal Tract After Cerebral Hemorrhage	34
Benign Paroxysmal Positional Vertigo: The “SemontPLUS Maneuver” is more effective than the Epley Maneuver – a Prospective Tri-national Randomized Single-Blinded Trial in 195 Patients (S12.003)	34
A Fatal Case of CNS Actinomyces Mimicking Tolosa-Hunt Syndrome: Is it Time to Reevaluate Diagnostic Criteria? (P10-10.004)	34
Cognitive sequelae in MOG antibody-associated disease (P13-5.025)	34
Socioeconomic Disparities in Aspiration Pneumonia Hospitalizations in Parkinson’s Disease Patients (P2-5.006)	34